Effect of a protease inhibitor-induced genetic bottleneck on human immunodeficiency virus type 1 env gene populations.
about
Extensive recombination among human immunodeficiency virus type 1 quasispecies makes an important contribution to viral diversity in individual patients.Contribution of Recombination to the Evolution of Human Immunodeficiency Viruses Expressing Resistance to Antiretroviral TreatmentContribution of human immunodeficiency virus type 1 minority variants to reduced drug susceptibility in patients on an integrase strand transfer inhibitor-based therapyHIV pathogenesis: dynamics and genetics of viral populations and infected cells.Association of HIV diversity and virologic outcomes in early antiretroviral treatment: HPTN 052.Impact of antiretroviral pressure on selection of primary human immunodeficiency virus type 1 envelope sequences in vitro.Co-lethality studied as an asset against viral drug escape: the HIV protease case.Evolution and recombination of genes encoding HIV-1 drug resistance and tropism during antiretroviral therapyGenetic Consequences of Antiviral Therapy on HIV-1.The remarkable frequency of human immunodeficiency virus type 1 genetic recombinationDriving HIV-1 into a Vulnerable Corner by Taking Advantage of Viral Adaptation and Evolution.Impaired human immunodeficiency virus type 1 replicative fitness in atypical viremic non-progressor individuals.Clinical resistance to enfuvirtide does not affect susceptibility of human immunodeficiency virus type 1 to other classes of entry inhibitors.Fitness landscape of human immunodeficiency virus type 1 protease quasispecies.
P2860
Q22242225-98C9601E-A9CA-4221-9DA9-33E12E47D191Q22242229-2840016B-558E-4A51-AB80-C75FBEDA4E1DQ28541754-3E1A1416-74FA-45F0-B03E-5CCD891CF5D0Q30425443-E45DAD1C-5D3D-45C7-8678-65113419D785Q33648264-7E7133A2-86B5-4965-96C4-58AC6EA1D941Q33887352-FC965210-842A-47BC-A0EE-B02578657012Q33968760-3792D990-8B27-47FE-8A1E-3A1819B27B15Q35264750-7DE9F296-62E2-4E98-8895-83A43EFE4D10Q35773113-1DB16F7C-D390-4ABA-95D2-1CC0C1F22447Q37333701-EB0D4DE2-4462-4AE2-B777-B2B1014C3746Q37703084-274F4EF8-6E18-4821-9D1C-DB98D6B7C9FAQ37713470-10A0B593-32A0-4A9E-97FB-E8D49D963A99Q40179461-32180380-4153-4C0C-8F12-74D5400AEAEAQ42089613-DF94810A-74DD-4301-9F45-B9A90F1F54FA
P2860
Effect of a protease inhibitor-induced genetic bottleneck on human immunodeficiency virus type 1 env gene populations.
description
2005 nî lūn-bûn
@nan
2005 թուականի Օգոստոսին հրատարակուած գիտական յօդուած
@hyw
2005 թվականի օգոստոսին հրատարակված գիտական հոդված
@hy
2005年の論文
@ja
2005年論文
@yue
2005年論文
@zh-hant
2005年論文
@zh-hk
2005年論文
@zh-mo
2005年論文
@zh-tw
2005年论文
@wuu
name
Effect of a protease inhibitor ...... s type 1 env gene populations.
@ast
Effect of a protease inhibitor ...... s type 1 env gene populations.
@en
type
label
Effect of a protease inhibitor ...... s type 1 env gene populations.
@ast
Effect of a protease inhibitor ...... s type 1 env gene populations.
@en
prefLabel
Effect of a protease inhibitor ...... s type 1 env gene populations.
@ast
Effect of a protease inhibitor ...... s type 1 env gene populations.
@en
P2093
P2860
P1433
P1476
Effect of a protease inhibitor ...... s type 1 env gene populations.
@en
P2093
Julie A E Nelson
Kathryn M Kitrinos
Wolfgang Resch
P2860
P304
10627-10637
P356
10.1128/JVI.79.16.10627-10637.2005
P407
P577
2005-08-01T00:00:00Z